Advertisement

Topics

Calyxt Files Registration Statement for Proposed Initial Public Offering

12:45 EDT 23 Jun 2017 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
Regulatory News: Cellectis S.A. (Alternext : ALCLS ; Nasdaq : CLLS) and Calyxt, Inc. announced that Calyxt has publicly filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission (SEC) r...

Other Sources for this Article

Media
Jennifer Moore, VP Communications
Phone: 917-580-1088
email: media@calyxt.com / media@cellectis.com
or
Caitlin Kasunich / Nick Opich
KCSA Strategic Communications
Phone: 212-896-1241 / 212-896-1206
email: ckasunich@kcsa.com / nopich@kcsa.com
or
Investor Relations
Simon Harnest, VP Corporate Strategy and Finance
Phone: 646-385-9008
email: simon.harnest@cellectis.com

NEXT ARTICLE

More From BioPortfolio on "Calyxt Files Registration Statement for Proposed Initial Public Offering"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Bioinformatics
Bioinformatics is the application of computer software and hardware to the management of biological data to create useful information. Computers are used to gather, store, analyze and integrate biological and genetic information which can then be applied...

Rheumatology
Arthritis Fibromyalgia Gout Lupus Rheumatic Rheumatology is the medical specialty concerned with the diagnosis and management of disease involving joints, tendons, muscles, ligaments and associated structures (Oxford Medical Diction...